Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Usana Health Sciences (USNA) Change in Accured Expenses (2016 - 2025)

Historic Change in Accured Expenses for Usana Health Sciences (USNA) over the last 15 years, with Q3 2025 value amounting to -$1.4 million.

  • Usana Health Sciences' Change in Accured Expenses fell 12047.17% to -$1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$12.5 million, marking a year-over-year decrease of 102957.62%. This contributed to the annual value of -$6.7 million for FY2024, which is 7754.21% up from last year.
  • As of Q3 2025, Usana Health Sciences' Change in Accured Expenses stood at -$1.4 million, which was down 12047.17% from -$38000.0 recorded in Q2 2025.
  • In the past 5 years, Usana Health Sciences' Change in Accured Expenses ranged from a high of $14.5 million in Q4 2022 and a low of -$29.8 million during Q1 2022
  • Moreover, its 5-year median value for Change in Accured Expenses was -$4.8 million (2024), whereas its average is -$5.7 million.
  • The largest annual percentage gain for Usana Health Sciences' Change in Accured Expenses in the last 5 years was 43286.36% (2024), contrasted with its biggest fall of 70274.31% (2024).
  • Over the past 5 years, Usana Health Sciences' Change in Accured Expenses (Quarter) stood at -$13.7 million in 2021, then surged by 205.57% to $14.5 million in 2022, then crashed by 94.47% to $802000.0 in 2023, then tumbled by 702.74% to -$4.8 million in 2024, then surged by 71.99% to -$1.4 million in 2025.
  • Its Change in Accured Expenses was -$1.4 million in Q3 2025, compared to -$38000.0 in Q2 2025 and -$6.3 million in Q1 2025.